However, from the results of increased ratio of LC3B II/LC3B I and decreased mTOR levels in this study, of which the former proves positive regulate factor of autophagy and the latter is negative22–24, autophagy seems not contribute to olanzapine-induced hepatic steatosis. The gene discussed is MTOR; the disease is fatty liver disease.